In more detail, SDG supplementation attenuated colitis severity, reduced macrophage infiltration, and lowered inflammatory cytokine levels while inhibiting NLRP1 inflammasome activation, partly through NF-κB disruption, suggesting its potential as an IBD treatment 453. This evidence concerns the gene NFKB1 and colitis.